12 Best Small Cap Pharma Stocks to Buy Now
Emily Field, Head of European Pharma Research at Barclays, spoke on CNBC on February 20 about the performance of obesity medications, the effects of US tariffs, and the dynamics of the pharmaceutical ...
Ironwood Pharmaceuticals Inc (IRWD)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | 92,740,000 | $85,206,067 | 2.52% | ||
| 2. | Sarissa Capital Management Alex Denner | 16,390,000 | $72,607,700 | 22.48% | |
| 3. | Armistice Capital Steven Boyd | 9,468,000 | $41,943,240 | +16% | 0.57% |
| 4. | Renaissance Technologies Jim Simons | 9,066,241 | $40,163,448 | +6% | 0.05% |
| 5. | Braidwell LP Alex Karnal | 5,440,277 | $24,100,427 | +23% | 0.71% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.70 | 6,920 | 121,028 | 2024-03-06 | Filing | ||
| $9.38 | 10,684 | 301,733 | 2024-03-04 | Filing | ||
| $8.32 | 36,072 | Officer | 188,730 | 2023-09-15 | Filing | |
| $10.54 | 75,000 | Large Shareholder, Director | 16,390,000 | 2021-03-10 | Filing | |
| $10.30 | 150,000 | Large Shareholder, Director | 16,315,000 | 2021-03-08 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.76 | 139,064 | 1,160,634 | 2025-02-10 | Filing | ||
| $1.76 | 12,048 | 279,655 | 2025-02-10 | Filing | ||
| $1.76 | 41,269 | 554,007 | 2025-02-10 | Filing | ||
| $1.76 | 38,938 | 408,132 | 2025-02-10 | Filing | ||
| $1.76 | 12,052 | 183,810 | 2025-02-10 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 23,037,335 | $102,055,393 | 0% | |
| 2. | 19,538,555 | $86,555,798 | 0% | |
| 3. | 11,730,771 | $51,967,316 | 0.11% | |
| 4. | Ubs Group AgCALL | 11,200,320 | $49,617,418 | 0.02% |
| 5. | 8,328,817 | $36,896,659 | 0% |
News See All
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2024 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2024 Earnings Call Transcript February 27, 2025Ironwood Pharmaceuticals, Inc. misses on earnings expectations.
Here’s Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD)
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded...
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2024 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q3 2024 Earnings Call Transcript November 7, 2024Ironwood Pharmaceuticals, Inc. misses on earnings expectations.
8 Penny Stocks with Biggest Upside Potential According to Analysts
The Federal Reserve slashed interest rates by a half point in September, kickstarting its first easing campaign in four years.
10 Best Multibagger Penny Stocks of 2025
The term "multibagger" was coined by Peter Lynch in his book titled "One Up On Wall Street" to describe those stocks whose share prices increase several times more than an investor's original investment...
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q2 2024 Earnings Call Transcript
Operator: Thank you for standing by. My name, Celine, and I will be your conference operator today.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.08927 EPS, expectations were $0.18. Ironwood Pharmaceuticals, Inc.
5 Best Low Price Pharma Stocks To Invest In
In this piece, we will take a look at the five best low price pharma stocks to invest in.
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q4 2023 Earnings Call Transcript
Ironwood Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.01 EPS, expectations were $0.2.